Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:Delineation of organs at risk is a time-consuming task. This study evaluates the benefits of using single-subject atlas-based automatic segmentation of organs at risk in patients with breast cancer treated in prone position, with 2 different criteria for choosing the atlas subject. Together with laterality (left/right), the criteria used were either (1) breast volume or (2) body mass index and breast...
Tue Apr 21, 2020 13:27
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Purpose:Setup uncertainty is a known challenge for stereotactic body radiotherapy planning. Using the internal target volume-based robust optimization was proposed as a more accurate way than the conventional planning target volume-based optimization when considering the robustness criteria. In this study, we aim to investigate the feasibility of internal target volume-based robust optimization in stereotactic...
Tue Apr 21, 2020 13:25
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:The aim of the present research is to study the roles of miR-203a-3p on cell proliferation, migration, invasion, and epithelial–mesenchymal transition in pancreatic cancer.Methods:Transcription profiles were acquired from Gene Expression Omnibus database, which was used to screen out the differentially expressed microRNAs and messenger RNAs in pancreatic cancer. Pancreatic cancer tissues were used to...
Fri Apr 17, 2020 12:32
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Rabs have been reported to be involved in the carcinogenesis process and in the progression of cancer. However, it is unclear whether or not Rab9 is associated with the development of cancer. In the present study, we aimed to investigate the role of Rab9 in the biological functions of gastric cancer cells. The gastric cancer cell lines AGS and MKN45 were transfected with siRNA-Rab9 to block the expression of Rab9....
Fri Apr 17, 2020 12:29
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:Nasopharyngeal carcinoma is highly endemic in Southeast China. Circulating tumor cell is an important biomarker in the prognosis of variety kinds of cancers. Overexpression of fibronectin 1 was observed in variety kinds of malignancies and may contribute to progress and metastasis of the cancers. The current study was aimed to investigate phenotypes of circulating tumor cell in nasopharyngeal carcinoma...
Mon Apr 13, 2020 14:04
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. The objective of this article is to study the effect of inhibiting phosphatase and tensin homolog deleted chromatosome 10 gene on phosphoinositide 3-kinase/protein kinase B (Akt)/Forkhead homeobox O3a signaling pathway in human nasopharyngeal carcinoma HK-1 cells. Nasopharyngeal carcinoma HK-1 cell lines were divided into PTEN gene interference group (siPTEN), nonspecific small interfering RNA group (siNC), empty...
Mon Apr 13, 2020 13:03
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. MicroRNAs are reported as a vital important factor in cancer cell initiation and progression processes. MicroRNA-19-3p has drawn the attention of many researchers in recent years because of its wide expression and its key role in serious kinds of tumor cells. However, the detailed mechanism of microRNA-19a-3p in these tumors is still poorly understood. So, in the present study, we aimed to explore the biological...
Wed Apr 08, 2020 13:03
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. RNA-binding proteins have been associated with cancer development. The overexpression of a well-known RNA-binding protein, insulin-like growth factor 2 messenger RNA–binding protein 3, has been identified as an indicator of poor prognosis in patients with various types of cancer. Although gastric cancer is a relatively frequent and potentially fatal malignancy, the mechanism by which insulin-like growth factor...
Wed Apr 08, 2020 13:00
Mark above section as read
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Volume 16, Issue 12, Page 793-803, April 2020.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Volume 16, Issue 12, Page 733-748, April 2020.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
Future Oncology, Volume 16, Issue 11, Page 615-617, April 2020.
Mark above section as read
Sprache Stimme GehörDOI: 10.1055/a-1043-7822© Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents | Full text
Sprache Stimme GehörDOI: 10.1055/a-1043-7259© Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents | Full text
Sprache Stimme GehörDOI: 10.1055/a-0867-7927 Hintergrund Es sollte die weitere sprachliche Entwicklung von Kindern, die mit 24 Monaten die Kriterien eines Late Talkers erfüllt hatten und mit 2½ Jahren noch immer als sprachentwicklungsverzögert eingestuft wurden, bis zum Alter von 3 Jahren erfasst werden. Zudem war es Ziel, prognostische Faktoren zu identifizieren, mittels derer ein Auf- bzw. Nicht-Aufholen bis zum Alter von 3 Jahren vorhergesagt werden kann. Methode Mittels...
Mark above section as read
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου